GLP-2 Tirzepatide (40mg vials)

Description

Tirzepatide is a synthetic, single-chain peptide engineered to engage two incretin receptor systems at once: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Its sequence carries a fatty-acid moiety that supports an extended circulating profile, making it a useful reference molecule for benchtop work on dual-agonist design and receptor pharmacology.

Within laboratory settings, this peptide is frequently used to probe how simultaneous activation of the GIP and GLP-1 pathways shapes downstream second-messenger cascades, receptor binding behavior, and signal transduction relative to single-receptor agonists. It serves as a structural and functional comparator across studies of incretin biology and engineered multi-target peptides.

This listing is supplied by Bolt Peptide as a lyophilized powder in a sealed glass vial at a 40mg fill weight. Material is prepared for controlled in vitro and analytical applications only.

• Investigations into GIP and GLP-1 receptor activation and binding kinetics
• Comparative studies of single- versus dual-agonist signaling profiles
• Structure-activity and peptide-engineering reference work
• Assay development and analytical method validation

Purity is assessed by HPLC with identity confirmed by mass spectrometry, and a batch-specific certificate of analysis accompanies each order. For handling, store the sealed lyophilized powder cold and shielded from light, reconstitute only with an appropriate solvent for your protocol, keep any reconstituted solution refrigerated, and avoid repeated freeze-thaw cycles to preserve peptide integrity.

Research Use Only: This material is supplied strictly for laboratory research. Not for human or animal consumption. It is not a drug, food, supplement, or cosmetic and has not been approved by the FDA.